375 related articles for article (PubMed ID: 16540649)
1. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells.
Ren J; Xiao YJ; Singh LS; Zhao X; Zhao Z; Feng L; Rose TM; Prestwich GD; Xu Y
Cancer Res; 2006 Mar; 66(6):3006-14. PubMed ID: 16540649
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of human peritoneal mesothelial cell co-culture-evoked malignant potential of ovarian cancer cells by acacetin involves LPA release-activated RAGE-PI3K/AKT signaling.
Tian M; Tang Y; Huang T; Liu Y; Pan Y
Cell Mol Biol Lett; 2021 Dec; 26(1):51. PubMed ID: 34886812
[TBL] [Abstract][Full Text] [Related]
3. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2.
Eder AM; Sasagawa T; Mao M; Aoki J; Mills GB
Clin Cancer Res; 2000 Jun; 6(6):2482-91. PubMed ID: 10873103
[TBL] [Abstract][Full Text] [Related]
4. [Effect of inhibitors of phospholipase A(2); on the metastasis potentials of human ovarian cancer cells].
Ren J; Li Y; Zhang YL; Zhou XH; Zhang L; Yang Y; Li Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Oct; 26(10):992-5. PubMed ID: 20937237
[TBL] [Abstract][Full Text] [Related]
5. A novel laminin-induced LPA autocrine loop in the migration of ovarian cancer cells.
Sengupta S; Xiao YJ; Xu Y
FASEB J; 2003 Aug; 17(11):1570-2. PubMed ID: 12824286
[TBL] [Abstract][Full Text] [Related]
6. SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk.
Said NA; Najwer I; Socha MJ; Fulton DJ; Mok SC; Motamed K
Neoplasia; 2007 Jan; 9(1):23-35. PubMed ID: 17325741
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway.
Bian D; Su S; Mahanivong C; Cheng RK; Han Q; Pan ZK; Sun P; Huang S
Cancer Res; 2004 Jun; 64(12):4209-17. PubMed ID: 15205333
[TBL] [Abstract][Full Text] [Related]
8. Mesothelial vitronectin stimulates migration of ovarian cancer cells.
Heyman L; Leroy-Dudal J; Fernandes J; Seyer D; Dutoit S; Carreiras F
Cell Biol Int; 2010 Apr; 34(5):493-502. PubMed ID: 20121701
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.
Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A
Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018
[TBL] [Abstract][Full Text] [Related]
10. Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment.
Reinartz S; Lieber S; Pesek J; Brandt DT; Asafova A; Finkernagel F; Watzer B; Nockher WA; Nist A; Stiewe T; Jansen JM; Wagner U; Konzer A; Graumann J; Grosse R; Worzfeld T; Müller-Brüsselbach S; Müller R
Mol Oncol; 2019 Feb; 13(2):185-201. PubMed ID: 30353652
[TBL] [Abstract][Full Text] [Related]
11. Calcium-independent phospholipase A(2) is required for human monocyte chemotaxis to monocyte chemoattractant protein 1.
Carnevale KA; Cathcart MK
J Immunol; 2001 Sep; 167(6):3414-21. PubMed ID: 11544333
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.
Kim KS; Sengupta S; Berk M; Kwak YG; Escobar PF; Belinson J; Mok SC; Xu Y
Cancer Res; 2006 Aug; 66(16):7983-90. PubMed ID: 16912173
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of calcium-independent phospholipase A2 suppresses proliferation and tumorigenicity of ovarian carcinoma cells.
Song Y; Wilkins P; Hu W; Murthy KS; Chen J; Lee Z; Oyesanya R; Wu J; Barbour SE; Fang X
Biochem J; 2007 Sep; 406(3):427-36. PubMed ID: 17555408
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
Sengupta S; Kim KS; Berk MP; Oates R; Escobar P; Belinson J; Li W; Lindner DJ; Williams B; Xu Y
Oncogene; 2007 May; 26(20):2894-901. PubMed ID: 17130843
[TBL] [Abstract][Full Text] [Related]
15. Amyloid beta(1-42) and its beta(25-35) fragment induce activation and membrane translocation of cytosolic phospholipase A2 in bovine retina capillary pericytes.
Anfuso CD; Assero G; Lupo G; Nicotra A; Cannavò G; Strosznajder RP; Rapisarda P; Pluta R; Alberghina M
Biochim Biophys Acta; 2004 Nov; 1686(1-2):125-38. PubMed ID: 15522829
[TBL] [Abstract][Full Text] [Related]
16. Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain.
Ma L; Uchida H; Nagai J; Inoue M; Aoki J; Ueda H
J Pharmacol Exp Ther; 2010 May; 333(2):540-6. PubMed ID: 20123931
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress contributes to hepatocyte growth factor-dependent pro-senescence activity of ovarian cancer cells.
Mikuła-Pietrasik J; Uruski P; Pakuła M; Maksin K; Szubert S; Woźniak A; Naumowicz E; Szpurek D; Tykarski A; Książek K
Free Radic Biol Med; 2017 Sep; 110():270-279. PubMed ID: 28652056
[TBL] [Abstract][Full Text] [Related]
18. A novel role of group VIB calcium-independent phospholipase A2 (iPLA2gamma) in the inducible expression of group IIA secretory PLA2 in rat fibroblastic cells.
Kuwata H; Fujimoto C; Yoda E; Shimbara S; Nakatani Y; Hara S; Murakami M; Kudo I
J Biol Chem; 2007 Jul; 282(28):20124-32. PubMed ID: 17475622
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells.
Symowicz J; Adley BP; Woo MM; Auersperg N; Hudson LG; Stack MS
Cancer Res; 2005 Mar; 65(6):2234-42. PubMed ID: 15781636
[TBL] [Abstract][Full Text] [Related]
20. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]